Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

real-world study

This page shows the latest real-world study news and features for those working in and with pharma, biotech and healthcare.

Roche’s Ocrevus boasts positive long-term data in MS

Roche’s Ocrevus boasts positive long-term data in MS

The new data comes from the open-label phase 3b CASTING study and the CONFIDENCE real-world safety study, in which Ocrevus was administered to RRMS patients who had experienced a ... New real-world OCREVUS data shows high persistence and adherence to the

Latest news

  • Charity launches real-world medical cannabis study Charity launches real-world medical cannabis study

    20, 000-patient pilot study in the UK. ... Called Project TWENTY21, the pilot intends to enrol the 20, 000 subjects by the end of 2021 and take a real-world approach to generating data on the safety, efficacy and

  • FDA starts review of Biogen’s Tecfidera follow-up for MS FDA starts review of Biogen’s Tecfidera follow-up for MS

    The US filing for Vumerity is a truncated package based on the EVOLVE-MS-1 study which showed it was bioequivalent to Tecfidera, along with pharmacokinetic bridging studies comparing the two ... Some also say that the side effects with Tecfidera are

  • Biogen files Tecfidera follow-up in the US Biogen files Tecfidera follow-up in the US

    Biogen is also enrolling patients a head-to-head tolerability study versus Tecfidera with data due in mid-2019. ... However, a recent ‘real-world’ study conducted in Sweden found that a majority of Tecfidera patients at one clinic – around 57% –

  • J&J’s Invokana aces diabetic kidney disease trial, setting up filings J&J’s Invokana aces diabetic kidney disease trial, setting up filings

    Johnson &Johnson’s SGLT2 inhibitor Invokana worked so well in a trial involving diabetics with chronic kidney disease that the study has been halted early – potentially opening up a lucrative new ... dapagliflozin). Since then J&J has been trying to

  • J&J says real-world data finds no amputation risk for Invokana J&J says real-world data finds no amputation risk for Invokana

    The study depicts how patients are faring on these drugs in the real-world, according to investigator John Buse of the University of North Carolina School of Medicine, who said the ... AZ is still waiting for data read-outs from its cardiovascular

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • The long and winding road to asthma breakthroughs The long and winding road to asthma breakthroughs

    The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world evidence study – presented at the recent European Respiratory Society’s International ... We also developed specific

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    An example is the landmark CVD-REAL study of more than 300, 000 patients. ... This is the first large real-world evidence study of its kind, evaluating the risk of hospitalisation for heart failure and death from any cause in patients with type 2

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    data. The importance of real-world data is growing rapidly, but its quality, taxonomy and accessibility are not standardised and once again require collaboration to pull it off. ... An example is the real-world observational study GSK conducted for its

  • The gold standard of scientific evidence The gold standard of scientific evidence

    However, randomisation can be incorporated into real-world study designs. For instance, pragmatic trial designs blend randomisation with real-world treatment practices. ... For starters, researchers should make available study protocols for all research

  • Case study: From Clinical Trials to Real-World Evidence Case study: From Clinical Trials to Real-World Evidence

    Client:Janssen. Agency:Havas Life Medicom. Campaign:From Clinical Trials to Real-World Evidence. Timescale:N/A. ... However, some stakeholders can be resistant to utilise the data gathered in real-world studies due to their observational nature.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • RWE Blog 1: Real-world challenges and real-world data

    Examples of cases where real-world-type outcomes are better than RCTs include:. ... Greater improvement of key clinical outcomes  in patients with diabetic macular oedema from a real-world study of a fluocinolone intravitreal implant, compared with the

  • Webinar: Demand assessment - Reflecting real world choices

    How study design which reflects doctors’ real world choices can optimise results. ... study design which reflects doctors’ real world choices can optimise results. .

  • Research Partnership

    Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients. ... How study design which reflects doctors’ real world choices can optimise results.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Communiqué Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Quick links

Infographics

Multimedia